Journal article
The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice
The Biochemical journal, Vol.461(1), pp.99-106
07/01/2014
DOI: 10.1042/BJ20140126
PMCID: PMC4277184
PMID: 24758151
Abstract
CASQ2 (cardiac calsequestrin) is commonly believed to serve as the SR (sarcoplasmic reticulum) luminal Ca2+ sensor. Ablation of CASQ2 promotes SCWs (spontaneous Ca2+ waves) and CPVT (catecholaminergic polymorphic ventricular tachycardia) upon stress but not at rest. How SCWs and CPVT are triggered by stress in the absence of the CASQ2-based luminal Ca2+ sensor is an important unresolved question. In the present study, we assessed the role of the newly identified RyR2 (ryanodine receptor 2)-resident luminal Ca2+ sensor in determining SCW propensity, CPVT susceptibility and cardiac hypertrophy in Casq2-KO (knockout) mice. We crossbred Casq2-KO mice with RyR2 mutant (E4872Q+/-) mice, which lack RyR2-resident SR luminal Ca2+ sensing, to generate animals with both deficiencies. Casq2+/- and Casq2-/- mice showed stress-induced VTs (ventricular tachyarrhythmias), whereas Casq2+/-/E4872Q+/- and Casq2-/-/E4872Q+/- mice displayed little or no stress-induced VTs. Confocal Ca2+ imaging revealed that Casq2-/- hearts frequently exhibited SCWs after extracellular Ca2+ elevation or adrenergic stimulation, whereas Casq2-/-/E4872Q+/- hearts had few or no SCWs under the same conditions. Cardiac hypertrophy developed and CPVT susceptibility increased with age in Casq2-/- mice, but not in Casq2-/-/E4872Q+/- mice. However, the amplitudes and dynamics of voltage-induced Ca2+ transients in Casq2-/- and Casq2-/-/E4872Q+/- hearts were not significantly different. Our results indicate that SCWs, CPVT and hypertrophy in Casq2-null cardiac muscle are governed by the RyR2-resident luminal Ca2+ sensor. This implies that defects in CASQ2-based lumi-nal Ca2+ sensing can be overridden by the RyR2-resident luminal Ca2+ sensor. This makes this RyR2-resident sensor a promising molecular target for the treatment of Ca2+-mediated arrhythmias.
Details
- Title: Subtitle
- The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice
- Creators
- Jingqun Zhang - Rush University Medical CenterBiyi Chen - University of IowaXiaowei Zhong - Libin Cardiovascular Institute of AlbertaTao Mi - Libin Cardiovascular Institute of AlbertaAng Guo - University of IowaQiang Zhou - Rush University Medical CenterZhen Tan - Rush University Medical CenterGuogen Wu - Rush University Medical CenterAlexander W Chen - University of CalgaryMichael Fill - Rush University Medical CenterLong-Sheng Song - University of IowaS R Wayne Chen - Libin Cardiovascular Institute of Alberta
- Resource Type
- Journal article
- Publication Details
- The Biochemical journal, Vol.461(1), pp.99-106
- DOI
- 10.1042/BJ20140126
- PMID
- 24758151
- PMCID
- PMC4277184
- NLM abbreviation
- Biochem J
- ISSN
- 0264-6021
- eISSN
- 1470-8728
- Grant note
- R01HL090905 / NHLBI NIH HHS R01 HL057832 / NHLBI NIH HHS R01 HL075210 / NHLBI NIH HHS R01 HL090905 / NHLBI NIH HHS R01HL057832 / NHLBI NIH HHS R01HL75210 / NHLBI NIH HHS
- Language
- English
- Date published
- 07/01/2014
- Academic Unit
- Cardiovascular Medicine; Fraternal Order of Eagles Diabetes Research Center; Biochemistry and Molecular Biology; Internal Medicine
- Record Identifier
- 9984293087102771
Metrics
7 Record Views